56948-76-6

Usage

InChI:InChI=1/C11H9F3O3/c12-11(13,14)8-3-1-2-7(6-8)9(15)4-5-10(16)17/h1-3,6H,4-5H2,(H,16,17)

Upstream product

• 108-30-5 succinic acid anhydride 
• 98-08-8 α,α,α-trifluorotoluene 

Downstream Products

• 93040-73-4 1-(4-Methyl-piperazin-1-yl)-4-(3-trifluoromethyl-phenyl)-butane-1,4-dione 
• 93061-41-7 N-sec-Butyl-4-oxo-4-(3-trifluoromethyl-phenyl)-butyramide 
• 93040-71-2 N-Isobutyl-4-oxo-4-(3-trifluoromethyl-phenyl)-butyramide 
• 93040-70-1 N-Isopropyl-4-oxo-4-(3-trifluoromethyl-phenyl)-butyramide 
• 166312-64-7 N,N-diethyl-4-(3-trifluoromethylphenyl)-4-oxobutanamide 
• 56948-73-3 5-hydroxy-1-methyl-5-(m-trifluoromethylphenyl)pyrrolidone 
• 106263-30-3 4,5-dihydro-2-(2-nitrophenyl)-6-<3-(trifluoromethyl)phenyl>-3(2H)-pyridazinone 
• 106263-34-7 2-(2-nitrophenyl)-6-<(3-trifluoromethyl)phenyl>-3(2H)-pyridazinone 
• 106263-40-5 2-(2-aminophenyl)-6-<3-(trifluoromethyl)phenyl>-3(2H)-pyridazinone 
• 106263-45-0 2-<3-(trifluoromethyl)phenyl>pyridazino<1,6-a>benzimidazole 
• 93040-69-8 N,N-Dimethyl-4-oxo-4-(3-trifluoromethyl-phenyl)-butyramide 
• 93040-72-3 N-Cyclohexyl-4-oxo-4-(3-trifluoromethyl-phenyl)-butyramide 

Relevant academic research and scientific papers

Synthesis of Enantiopure γ-Lactones via a RuPHOX-Ru Catalyzed Asymmetric Hydrogenation of γ-Keto Acids

A RuPHOX?Ru catalyzed asymmetric hydrogenation of γ-keto acids has been developed, affording the corresponding enantiopure γ-lactones in high yields and with up to 97% ee. The reaction could be performed on a gram scale with a relatively low catalyst loading (up to 10000 S/C) under the indicated reaction conditions and the resulting products can be transformed to several enantiopure building blocks, biologically active compounds and enantiopure drugs. (Figure presented.).

Insecticidal hydrazine derivatives

The present invention relates to a hydrazine derivative represented by the formula (I): STR1 (wherein each of Ar1 and Ar2 is a substituted or unsubstituted phenyl group, a substituted or unsubstituted heteroaryl group, or the like, R

SUBSTITUTED THIO-SUBSTITUTED BENZYL-PROPIONYL-L-PROLINES

This disclosure describes novel substituted ω-aroyl(propionyl or butyryl)-L-prolines and the esters and cationic salts thereof which are useful as hypotensive agents in mammals.